| Status of peripheral blood natural killer cells and cytotoxicity in women with recurrent pregnancy loss and unexplained infertility parviz kokhaei Azam Azargoon, Mahdieh Shokrollahi Barough, Mahdi Barati ... international journal of fertility and sterility 13 (1), 2019 | 39 | 2019 |
| ILP-2 modeling and virtual screening of an FDA-approved library: a possible anticancer therapy S Khalili, H Mohammadpour, MS Barough, P Kokhaei Turkish journal of medical sciences 46 (4), 1135-1143, 2016 | 29 | 2016 |
| Necroptosis Triggered by ROS Accumulation and Ca2+ Overload, Partly Explains the Inflammatory Responses and Anti-Cancer Effects Associated With 1Hz, 100 mT ELF-MF in vivo M Barati, MA Javidi, B Darvishi, SP Shariatpanahi, ZSM Moosavi, ... Free Radical Biology and Medicine 169, 84-98, 2021 | 26 | 2021 |
| Emerging Advances of Nanotechnology in Drug and Vaccine Delivery against Viral Associated Respiratory Infectious Diseases (VARID) MA Amir Seyfoori , Mahdieh Shokrollahi Barough , Pooneh Mokarram , Mazaher ... International journal of Molecular Sciences 22 (2), 1-37, 2021 | 24* | 2021 |
| Cimetidine effects on the immunosuppression induced by burn injury P Kokhaei, MS Barough, ZM Hassan International immunopharmacology 22 (1), 273-276, 2014 | 20 | 2014 |
| Apoptosis/necrosis induction by ultraviolet, in ER positive and ER negative breast cancer cell lines M Shokrollahi Barough, H Hasanzadeh, M Barati, F Pak, P Kokhaei, ... International Journal of Cancer Management 8 (6), 2015 | 16* | 2015 |
| Recombinant nanobody against MUC1 tandem repeats inhibits growth, invasion, metastasis and vascularization of spontaneous mouse mammary tumors LF Parnaz Merikhian, Behrad Darvishi, Neda Jalili, Mohammad Reza ... Molecular Oncology, 2021 | 13* | 2021 |
| Nano‑immunotherapy: overcoming delivery challenge of immune checkpoint therapy MS Seyed Hossein Kiaie, Hossein Salehi‑Shadkami, Mohammad Javad Sanaei ... Nanobiotechnology 21 (4), 339, 2023 | 12* | 2023 |
| Efficacy and safety of tofacitinib for treatment of alopecia areata in children: a systematic review and meta-analysis AG Elham Behrangi,Mahdieh Shokrollahi Barough,Maliheh Khoramdad,Pardis ... Journal of Cosmetic Dermatology 21 (9), 2022 | 12 | 2022 |
| Characterization of hydroxyapatite-reduced graphene oxide nanocomposites consolidated via high frequency induction heat sintering method RF Hassan Nosrati, Rasoul Sarraf-Mamoory, María Canillas, Mohammad Hossein ... Journal of Asian Ceramic Societies 14 (1), 1-14, 2020 | 9* | 2020 |
| Tumor immunology and tumor escape mechanisms from immune response. F Pak, M Barati, MS Barough, P Kokhaei | 8 | 2014 |
| Novel delivery of sorafenib by natural killer cell-derived exosomes-enhanced apoptosis in triple-negative breast cancer ZS Hashemi, M Ghavami, SH Kiaie, F Mohammadi, MS Barough, S Khalili, ... Nanomedicine 18 (5), 437-453, 2023 | 7 | 2023 |
| Decrease of tumor-infiltrating regulatory T cells using pentoxifylline: An ex vivo analysis in triple-negative breast cancer mouse model MH Kazemi, MS Barough, A Ghanavatinejad, Z Momeni-Varposhti, ... Iranian Journal of Allergy, Asthma and Immunology 21 (2), 167-177, 2022 | 7 | 2022 |
| Recent advances in gene therapy and modeling of chronic granulomatous disease A Jafarian, G Shokri, MS Barough, M Moin, Z Pourpak, M Soleimani Iranian Journal of Allergy, Asthma and Immunology, 2019 | 7 | 2019 |
| Immunopathology of multiple sclerosis. F Pak, T Nafariyeh, N Asghari, M Shokrollahy, P Kokhaei | 7 | 2013 |
| Effect of berberine on cancer cell viability of chronic lymphocytic leukemia patients in in vitro. F Ghahremanfard, A Aghabeigi, E Manouchehri, M Pashaei, ... | 6 | 2017 |
| Phase I non-randomized clinical trial of allogeneic natural killer cells infusion in acute myeloid leukemia patients AGRSF Mohammad Ahmadvand, Mahdieh Shokrollahi Barough, Maryam Barkhordar ... BMC Cancer 23 (1090), 2023 | 5 | 2023 |
| Evaluation of Interleukin 25 and Interleukin 25 Receptor Expression in Peripheral Blood Mononuclear Cells of Breast Cancer Patients and Normal Subjects AAMB Mehdi Barati, Maryam Sinaeian, Mahdieh Shokrollahi Barough, Fatemeh Pak ... Journal of Interferon & Cytokine Research 40 (0), 1-6, 2020 | 5* | 2020 |
| Neutralizing antibody production against Rebif® and ReciGen® in Relapsing- Remitting Multiple Sclerosis (RRMS) patients and its association with patient's disability PK Mahdieh Shokrollahi Barough, Fereshteh Ashtari, Mehdi Sadat Akhavi ... International Immunopharmacology 62, 109-113, 2018 | 5 | 2018 |
| Safety and feasibility study of ex vivo expanded allogeneic‑NK cells infusion in patients with acute pneumonia caused by COVID‑19 AGRSF Mohammad Ahmadvand, Mahdieh Shokrollahi Barough, Zahra Sadat Hashemi ... Pilot and Feasibility Studies 9 (137), 1-13, 2023 | 4* | 2023 |
